A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity

[1]  A. Udy,et al.  Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic , 2021, The Medical journal of Australia.

[2]  D. Brodie,et al.  Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19 , 2021, Nature Communications.

[3]  J. Rodríguez-Baño,et al.  LIVER MANIFESTATIONS IN COVID-19 AND THE INFLUENCE OF PRE-EXISTING LIVER DISEASE IN THE COURSE OF THE INFECTION. , 2021, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[4]  Shubinskaia Lv,et al.  Clinical characteristics and analysis of risk factors for disease progression of COVID-19: A retrospective Cohort Study , 2021, International journal of biological sciences.

[5]  G. D'offizi,et al.  COVID-19 disease—Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study , 2020, PloS one.

[6]  G. Garber,et al.  Epidemiology, clinical characteristics, household transmission, and lethality of severe acute respiratory syndrome coronavirus-2 infection among healthcare workers in Ontario, Canada , 2020, PloS one.

[7]  K. He,et al.  Independent and combined effects of hypertension and diabetes on clinical outcomes in patients with COVID‐19: A retrospective cohort study of Huoshen Mountain Hospital and Guanggu Fangcang Shelter Hospital , 2020, Journal of clinical hypertension.

[8]  C. Fischbacher,et al.  Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland , 2020, The Lancet Diabetes & Endocrinology.

[9]  M. Giorgi-Pierfranceschi.  Is aspirin effective in preventing ICU admission in patients with COVID-19 pneumonia? A comment to "Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19". , 2020, Anesthesia and analgesia.

[10]  R. Buhr,et al.  Obesity and smoking as risk factors for invasive mechanical ventilation in COVID-19: A retrospective, observational cohort study , 2020, PloS one.

[11]  W. Ji,et al.  Association of prescribed medications with the risk of COVID-19 infection and severity among adults in South Korea , 2020, International Journal of Infectious Diseases.

[12]  Yuehua Wu,et al.  Natural history of COVID-19: Risk factors for hospitalizations and deaths among >26 million U.S. Medicare beneficiaries , 2020, The Journal of infectious diseases.

[13]  Ming Xu,et al.  Diabetic patients with COVID-19 need more attention and better glycemic control , 2020, World journal of diabetes.

[14]  J. Kaldor,et al.  Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic , 2020, The Medical journal of Australia.

[15]  P. Laterre,et al.  Clinical characteristics and short-term prognosis of in-patients with diabetes and COVID-19: A retrospective study from an academic center in Belgium , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[16]  Gabriel Ștefan,et al.  Clinical features and outcome of maintenance hemodialysis patients with COVID-19 from a tertiary nephrology care center in Romania , 2020, Renal failure.

[17]  C. Kaymaz,et al.  Incidence of symptomatic venous thromboembolism following hospitalization for coronavirus disease 2019: Prospective results from a multi-center study , 2020, Thrombosis Research.

[18]  Qi Huang,et al.  Comparison of clinical characteristics among younger and elderly deceased patients with COVID-19: a retrospective study , 2020, Aging.

[19]  S. Yıldız,et al.  The Association between Chronic Use of Renin–Angiotensin-Aldosterone System Blockers and in-Hospital Adverse Events among COVID-19 Patients with Hypertension , 2020, Sisli Etfal Hastanesi tip bulteni.

[20]  R. Marfella,et al.  Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study , 2020, PloS one.

[21]  J. Espasandín-Domínguez,et al.  Development and validation of a prognostic model based on comorbidities to predict COVID-19 severity: a population-based study , 2020, International journal of epidemiology.

[22]  B. Özlek,et al.  Hydroxychloroquine/azithromycin treatment, QT interval and ventricular arrhythmias in hospitalised patients with COVID‐19 , 2020, International journal of clinical practice.

[23]  A. Druyan,et al.  The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: First wave lessons , 2020, Dermatologic therapy.

[24]  R. Rezaee,et al.  Increased age, neutrophil-to-lymphocyte ratio (NLR) and white blood cells count are associated with higher COVID-19 mortality , 2020, The American Journal of Emergency Medicine.

[25]  Florence Nassim Jean-David Didier Yannick Blanca Zahir Emma Aeschlimann Ait-Abdallah Albert Alcais A.  Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients , 2020, Annals of the Rheumatic Diseases.

[26]  S. Allahverdiyev,et al.  Assessment of the Relationship between Mortality and Troponin I Levels in Hospitalized Patients with the Novel Coronavirus (COVID-19) , 2020, Medicina.

[27]  Joseph M Pappachan,et al.  High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study , 2020, Nutrients.

[28]  Tayfun Çalışkan,et al.  Smoking and comorbidities are associated with COVID-19 severity and mortality in 565 patients treated in Turkey: a retrospective observational study. , 2020, Revista da Associacao Medica Brasileira.

[29]  N. Rosenthal,et al.  Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19 , 2020, JAMA network open.

[30]  Guo-bao Wu,et al.  Impact of renin–angiotensin system inhibitors use on mortality in severe COVID-19 patients with hypertension: a retrospective observational study , 2020, The Journal of international medical research.

[31]  M. Tennyson,et al.  Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19 , 2020, Scientific Reports.

[32]  P. Ciruela,et al.  The first wave of the COVID-19 pandemic in Spain: characterisation of cases and risk factors for severe outcomes, as at 27 April 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[33]  B. Tokgoz,et al.  Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  N. Al-Daghri,et al.  Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study , 2020, Cardiovascular Diabetology.

[35]  W. Bian,et al.  Prediction of disease progression in patients with COVID-19 by artificial intelligence assisted lesion quantification , 2020, Scientific Reports.

[36]  F. Schuelter-Trevisol,et al.  Assessment of patients with Covid-19 hospitalized in southern Santa Catarina , 2020, Revista da Sociedade Brasileira de Medicina Tropical.

[37]  M. Coffee,et al.  Comorbidity and clinical factors associated with COVID-19 critical illness and mortality at a large public hospital in New York City in the early phase of the pandemic (March-April 2020) , 2020, PloS one.

[38]  S. Rangaraju,et al.  C-Reactive protein as a prognostic indicator in hospitalized patients with COVID-19 , 2020, PloS one.

[39]  D. Dey,et al.  Epicardial adipose tissue is associated with extent of pneumonia and adverse outcomes in patients with COVID-19 , 2020, Metabolism.

[40]  V. S. Santos,et al.  Factors Associated with Mortality among Hospitalized Patients with COVID-19: A Retrospective Cohort Study , 2020, The American journal of tropical medicine and hygiene.

[41]  Benjamin Bowe,et al.  Acute Kidney Injury in a National Cohort of Hospitalized US Veterans with COVID-19. , 2020, Clinical journal of the American Society of Nephrology : CJASN.

[42]  Dongyin Zhang,et al.  Clinical characteristics and fatal outcomes of hypertension in patients with severe COVID-19 , 2020, Aging.

[43]  A. Farcomeni,et al.  JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality , 2020, Science Advances.

[44]  Richard S. Kwon,et al.  Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19 , 2020, Gastroenterology.

[45]  M. Metra,et al.  Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study , 2020, European journal of heart failure.

[46]  N. Al-Daghri,et al.  Prevalence of diabetes, management and outcomes among Covid-19 adult patients admitted in a specialized tertiary hospital in Riyadh, Saudi Arabia , 2020, Diabetes Research and Clinical Practice.

[47]  A. Assiri,et al.  Risk factors associated with worse outcomes in COVID-19: a retrospective study in Saudi Arabia. , 2020, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[48]  D. Coen,et al.  Clinical characteristics and respiratory support of 310 COVID-19 patients, diagnosed at the emergency room: a single-center retrospective study , 2020, Internal and Emergency Medicine.

[49]  F. Wang,et al.  Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19) , 2020, BMC Cardiovascular Disorders.

[50]  D. Burkhoff,et al.  Admission Cardiac Diagnostic Testing with Electrocardiography and Troponin Measurement Prognosticates Increased 30‐Day Mortality in COVID‐19 , 2020, Journal of the American Heart Association.

[51]  J. Hippisley-Cox,et al.  Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people , 2020, Heart.

[52]  Xiaowei Wu,et al.  A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19 , 2020, PloS one.

[53]  Chuanhua Yu,et al.  Epidemiological characteristics of patients with severe COVID-19 infection in Wuhan, China: evidence from a retrospective observational study , 2020, International journal of epidemiology.

[54]  M. Gould,et al.  Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score , 2020, The American Journal of Emergency Medicine.

[55]  C. Shah,et al.  Factors associated with increased mortality in hospitalized COVID-19 patients , 2020, Annals of Medicine and Surgery.

[56]  D. Kazi,et al.  Outcomes of COVID-19 in Patients With a History of Cancer and Comorbid Cardiovascular Disease. , 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

[57]  T. Felton,et al.  Characteristics and outcomes of hospitalised patients with acute kidney injury and COVID-19 , 2020, PloS one.

[58]  D. Annane,et al.  Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome. , 2020, The Journal of clinical investigation.

[59]  S. Tobis,et al.  Clinical Characteristics and Survival Analysis in a Small Sample of Older COVID-19 Patients with Defined 60-Day Outcome , 2020, International journal of environmental research and public health.

[60]  C. Annweiler,et al.  Vitamin D Supplementation Associated to Better Survival in Hospitalized Frail Elderly COVID-19 Patients: The GERIA-COVID Quasi-Experimental Study , 2020, Nutrients.

[61]  P. Bentley,et al.  COVID-19 outcomes in UK centre within highest health and wealth band: a prospective cohort study , 2020, BMJ Open.

[62]  R. Piccolo,et al.  Coronary artery disease in patients hospitalised with Coronavirus disease 2019 (COVID-19) infection , 2020, Open Heart.

[63]  E. Hussain,et al.  Risk factors for intensive care unit admission and mortality in hospitalized COVID-19 patients , 2020, Acute and critical care.

[64]  Geun U Park,et al.  Clinical Characteristics and Risk Factors for Fatality and Severity in Patients with Coronavirus Disease in Korea: A Nationwide Population-Based Retrospective Study Using the Korean Health Insurance Review and Assessment Service (HIRA) Database , 2020, International journal of environmental research and public health.

[65]  A. Nahvijou,et al.  Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran. , 2020, Archives of Iranian medicine.

[66]  J. Hirsch,et al.  BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID‐19 in New York , 2020, Obesity.

[67]  Fangcao Liu,et al.  Myocardial Injury at Early Stage and Its Association With the Risk of Death in COVID-19 Patients: A Hospital-Based Retrospective Cohort Study , 2020, Frontiers in Cardiovascular Medicine.

[68]  J. Jakobsson,et al.  Risk factors for death in adult COVID-19 patients: Frailty predicts fatal outcome in older patients , 2020, International Journal of Infectious Diseases.

[69]  J. Ramos-Rincón,et al.  Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19 , 2020, Journal of clinical medicine.

[70]  C. Hertogh,et al.  Clinical Suspicion of COVID-19 in Nursing Home Residents: Symptoms and Mortality Risk Factors , 2020, Journal of the American Medical Directors Association.

[71]  Lyanne M. Kieneker,et al.  COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration , 2020, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[72]  R. F. do Carmo,et al.  Clinical manifestations and factors associated with mortality from COVID‐19 in older adults: Retrospective population‐based study with 9807 older Brazilian COVID‐19 patients , 2020, Geriatrics & gerontology international.

[73]  M. Méndez-Bailon,et al.  Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[74]  S. Goldhaber,et al.  Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[75]  T. Fan,et al.  Comparison of clinical characteristics of COVID-19 between elderly patients and young patients: a study based on a 28-day follow-up , 2020, Aging.

[76]  Samin K. Sharma,et al.  Characterization of Myocardial Injury in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[77]  Gang Wu,et al.  The importance of overweight in COVID-19 , 2020, Medicine.

[78]  M. Kuiper,et al.  Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study , 2020, The Lancet Respiratory Medicine.

[79]  O. Wazni,et al.  Clinical Characteristics and Outcomes of Non-ICU Hospitalization for COVID-19 in a Nonepicenter, Centrally Monitored Healthcare System. , 2020, Journal of hospital medicine.

[80]  Samuel M. Galvagno,et al.  Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019 , 2020, Anesthesia and analgesia.

[81]  A. Kabir,et al.  Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study , 2020, Internal and Emergency Medicine.

[82]  R. Keogh,et al.  COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults , 2020, Annals of Internal Medicine.

[83]  A. Sheikh,et al.  Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study , 2020, BMJ.

[84]  P. Rochon,et al.  Sex differences in clinical phenotype and transitions of care among individuals dying of COVID-19 in Italy , 2020, Biology of sex differences.

[85]  Samantha K. Brenner,et al.  AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19. , 2020, Journal of the American Society of Nephrology : JASN.

[86]  A. Rodríguez-Molinero,et al.  Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients , 2020, PloS one.

[87]  P. Guisado-Vasco,et al.  Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort) , 2020, EClinicalMedicine.

[88]  G. Nardi,et al.  Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: multicenter observational study in fifteen Italian ICUs , 2020, Journal of Intensive Care.

[89]  R. Providência,et al.  Ethnicity and COVID-19 cardiovascular complications: a multi-center UK cohort. , 2020, American journal of cardiovascular disease.

[90]  J. Zenilman,et al.  Outcomes of Nursing Home COVID-19 Patients by Initial Symptoms and Comorbidity: Results of Universal Testing of 1970 Residents , 2020, Journal of the American Medical Directors Association.

[91]  J. Rajter,et al.  Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019 , 2020, Chest.

[92]  S. Kapur,et al.  COVID-19 outcomes in patients waitlisted for kidney transplantation and kidney transplant recipients , 2020, American Journal of Transplantation.

[93]  A. Mangoni,et al.  The De Ritis ratio as prognostic biomarker of in‐hospital mortality in COVID‐19 patients , 2020, European journal of clinical investigation.

[94]  C. Plymen,et al.  The effect of concomitant COVID‐19 infection on outcomes in patients hospitalized with heart failure , 2020, ESC heart failure.

[95]  Xuefeng Yu,et al.  Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019 , 2020, Journal of diabetes investigation.

[96]  P. Pelosi,et al.  Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO) , 2020, Frontiers in Cardiovascular Medicine.

[97]  Mario Silva,et al.  Chest X-ray for predicting mortality and the need for ventilatory support in COVID-19 patients presenting to the emergency department , 2020, European Radiology.

[98]  M. Zvolensky,et al.  Correlates of death among SARS-CoV-2 positive veterans: The contribution of lifetime tobacco use , 2020, Addictive Behaviors.

[99]  M. Malaise,et al.  Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection , 2020, The Journal of Allergy and Clinical Immunology: In Practice.

[100]  Jianfang Liu,et al.  Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study , 2020, BioMed research international.

[101]  Lan Huang,et al.  Influence of blood pressure control and application of renin‐angiotensin‐aldosterone system inhibitors on the outcomes in COVID‐19 patients with hypertension , 2020, Journal of clinical hypertension.

[102]  J. Nachega,et al.  Clinical Characteristics and Outcomes of Patients Hospitalized for COVID-19 in Africa: Early Insights from the Democratic Republic of the Congo , 2020, The American journal of tropical medicine and hygiene.

[103]  Saad Zbiri,et al.  C-reactive protein as an early predictor of COVID-19 severity , 2020, Journal of medical biochemistry.

[104]  A. Bassily-Marcus,et al.  Timing of Intubation and In-Hospital Mortality in Patients With Coronavirus Disease 2019 , 2020, Critical care explorations.

[105]  P. Rieu,et al.  Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort , 2020, Clinical kidney journal.

[106]  M. El-Mokhtar,et al.  Predictors of Severity and Co-Infection Resistance Profile in COVID-19 Patients: First Report from Upper Egypt , 2020, Infection and drug resistance.

[107]  T. Guo,et al.  Combined Interventions for Severe Novel Coronavirus Disease (COVID-19): Experience from 350 Patients , 2020, Infection and drug resistance.

[108]  L. Abu-Raddad,et al.  Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020 , 2020, BMJ Open.

[109]  N. Kolhe,et al.  Acute kidney injury associated with COVID-19: A retrospective cohort study , 2020, PLoS medicine.

[110]  Matthew Li,et al.  The Association Between BMI and Inpatient Mortality Outcomes in Older Adults With COVID-19 , 2020, Cureus.

[111]  J. Arenillas,et al.  Anosmia is associated with lower in-hospital mortality in COVID-19 , 2020, Journal of the Neurological Sciences.

[112]  A. Zaniboni,et al.  Outcome of oncological patients admitted with COVID-19: experience of a hospital center in northern Italy , 2020, Therapeutic advances in medical oncology.

[113]  C. Sánchez-Piedra,et al.  Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients , 2020, Public Health.

[114]  Nagehan Didem Sarı,et al.  A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality , 2020, Journal of Infection and Public Health.

[115]  Samantha K. Brenner,et al.  In-hospital cardiac arrest in critically ill patients with covid-19: multicenter cohort study , 2020, BMJ.

[116]  M. Topmiller,et al.  Outcomes of Hospitalized COVID-19 Patients by Risk Factors: Results from a United States Hospital Claims Database , 2020, Journal of health economics and outcomes research.

[117]  R. Akhavan,et al.  Evaluation of the relationship between inpatient COVID-19 mortality and chest CT severity score , 2020, The American Journal of Emergency Medicine.

[118]  Jae Hoon Lee,et al.  Effect of sex hormones on coronavirus disease 2019: an analysis of 5,061 laboratory-confirmed cases in South Korea , 2020, Menopause.

[119]  Shan Tian,et al.  Impacts of Type 2 Diabetes on Disease Severity, Therapeutic Effect, and Mortality of Patients With COVID-19 , 2020, The Journal of clinical endocrinology and metabolism.

[120]  M. Cecconi,et al.  The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy , 2020, International Journal of Cardiology.

[121]  N. Chen,et al.  Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort , 2020, Internal and Emergency Medicine.

[122]  Beau B. Bruce,et al.  Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  G. Anzola,et al.  Neither ACEIs nor ARBs are associated with respiratory distress or mortality in COVID-19 results of a prospective study on a hospital-based cohort , 2020, Internal and Emergency Medicine.

[124]  S. Altın,et al.  Could ferritin level be an indicator of COVID‐19 disease mortality? , 2020, Journal of medical virology.

[125]  J. Bonventre,et al.  Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study , 2020, Diabetes Care.

[126]  F. Herrmann,et al.  Predictors of In-Hospital Mortality in Older Patients With COVID-19: The COVIDAge Study , 2020, Journal of the American Medical Directors Association.

[127]  Irene Rethemiotaki.  A preliminary study of coronavirus disease 2019 in China: the impact of cardiovascular disease on death risk , 2020, Archives of medical sciences. Atherosclerotic diseases.

[128]  C. Fung,et al.  Predicting severe outcomes in Covid-19 related illness using only patient demographics, comorbidities and symptoms , 2020, The American Journal of Emergency Medicine.

[129]  M. Mandel,et al.  End-Stage Renal Disease Patients on Chronic Hemodialysis Fare Better With COVID-19: A Retrospective Cohort Study From the New York Metropolitan Region , 2020, Cureus.

[130]  S. Kalnicki,et al.  Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York , 2020, JAMA network open.

[131]  V. Fan,et al.  Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection , 2020, JAMA network open.

[132]  S. Smirnakis,et al.  Characteristics and Outcomes of Latinx Patients With COVID-19 in Comparison With Other Ethnic and Racial Groups , 2020, Open forum infectious diseases.

[133]  R. Grilli,et al.  Characteristics and outcomes of a cohort of COVID-19 patients in the Province of Reggio Emilia, Italy , 2020, PloS one.

[134]  I. Bassett,et al.  Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19 , 2020, Diabetes Care.

[135]  F. Falahati,et al.  Survival rate in hypertensive patients with COVID-19 , 2020, Clinical and experimental hypertension.

[136]  S. Czernichow,et al.  Obesity Doubles Mortality in Patients Hospitalized for Severe Acute Respiratory Syndrome Coronavirus 2 in Paris Hospitals, France: A Cohort Study on 5,795 Patients , 2020, Obesity.

[137]  Jeri Albano,et al.  The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis , 2020, Acta Diabetologica.

[138]  Jie Cao,et al.  Risk factors for severe cases of COVID-19: a retrospective cohort study , 2020, Aging.

[139]  M. Abate,et al.  Outcomes of patients with end-stage kidney disease hospitalized with COVID-19 , 2020, Kidney International.

[140]  E. Calzolari,et al.  Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy , 2020, Clinical Microbiology and Infection.

[141]  N. López-Villalobos,et al.  Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico , 2020, Annals of Epidemiology.

[142]  D. Brodie,et al.  Association Between Antecedent Statin Use and Decreased Mortality in Hospitalized Patients with COVID-19 , 2020, Research square.

[143]  Ganzhu Feng,et al.  Clinical characteristics of moderate COVID‐19 patients aggravation in Wuhan Stadium Cabin Hospital: A 571 cases of retrospective cohort study , 2020, Journal of medical virology.

[144]  Mahsa Akhbari,et al.  The association between cardiac injury and outcomes in hospitalized patients with COVID-19 , 2020, Internal and Emergency Medicine.

[145]  E. Klang,et al.  Sex Differences in Age and Comorbidities for COVID-19 Mortality in Urban New York City , 2020, SN Comprehensive Clinical Medicine.

[146]  M. Rizzo,et al.  Gender differences in the battle against COVID‐19: Impact of genetics, comorbidities, inflammation and lifestyle on differences in outcomes , 2020, International journal of clinical practice.

[147]  B. Hota,et al.  Clinical Course and Factors Associated With Hospitalization and Critical Illness Among COVID‐19 Patients in Chicago, Illinois , 2020, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[148]  S. Agarwal,et al.  Preadmission Diabetes-Specific Risk Factors for Mortality in Hospitalized Patients With Diabetes and Coronavirus Disease 2019 , 2020, Diabetes Care.

[149]  J. Lefante,et al.  BMI is Associated with Coronavirus Disease 2019 Intensive Care Unit Admission in African Americans , 2020, Obesity.

[150]  D. Podzamczer,et al.  Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain , 2020, Clinical Microbiology and Infection.

[151]  L. Carmona,et al.  Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study , 2020, Annals of the Rheumatic Diseases.

[152]  S. Mallipattu,et al.  Outcomes Associated with the Use of Renin-Angiotensin-Aldosterone System Blockade in Hospitalized Patients with SARS-CoV-2 Infection. , 2020, Kidney360.

[153]  I. Pavord,et al.  Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people , 2020, Heart.

[154]  Chunrui Li,et al.  Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study , 2020, EClinicalMedicine.

[155]  Jianguo Gao,et al.  High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study , 2020, Aging.

[156]  A. Singer,et al.  Prediction model and risk scores of ICU admission and mortality in COVID-19 , 2020, PloS one.

[157]  G. Weiss,et al.  Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection , 2020, Journal of clinical medicine.

[158]  J. Boyce,et al.  Risk factors for hospitalization, intensive care, and mortality among patients with asthma and COVID-19 , 2020, Journal of Allergy and Clinical Immunology.

[159]  J. Gugenheim,et al.  The Impact of Previous History of Bariatric Surgery on Outcome of COVID-19. A Nationwide Medico-Administrative French Study , 2020, Obesity Surgery.

[160]  L. Celi,et al.  The Minimal Effect of Zinc on the Survival of Hospitalized Patients With COVID-19 , 2020, Chest.

[161]  M. Foracchia,et al.  SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia , 2020, Biology.

[162]  M. González-Block,et al.  Increased Risk of Hospitalization and Death in Patients with COVID-19 and Pre-existing Noncommunicable Diseases and Modifiable Risk Factors in Mexico , 2020, Archives of Medical Research.

[163]  D. Melzer,et al.  Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort , 2020, The journals of gerontology. Series A, Biological sciences and medical sciences.

[164]  M. Mandel,et al.  Incidence and Risk Factors for Acute Kidney Injury and Its Effect on Mortality in Patients Hospitalized From COVID-19 , 2020, Mayo Clinic Proceedings: Innovations, Quality & Outcomes.

[165]  H. Dupont,et al.  Characteristics and outcomes of COVID‐19 in hospitalized patients with and without diabetes , 2020, Diabetes/metabolism research and reviews.

[166]  D. Rizzoni,et al.  Early use of low dose tocilizumab in patients with COVID-19: A retrospective cohort study with a complete follow-up , 2020, EClinicalMedicine.

[167]  X. Castells,et al.  Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain , 2020, Archivos de Bronconeumología.

[168]  R. Bertollini,et al.  The first consecutive 5000 patients with Coronavirus Disease 2019 from Qatar; a nation-wide cohort study , 2020, BMC Infectious Diseases.

[169]  B. Qiao,et al.  The diagnostic and prognostic role of myocardial injury biomarkers in hospitalized patients with COVID-19 , 2020, Clinica Chimica Acta.

[170]  M. Antonelli,et al.  Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy. , 2020, JAMA internal medicine.

[171]  G. Condorelli,et al.  Risk factors for myocardial injury and death in patients with COVID-19: insights from a cohort study with chest computed tomography , 2020, Cardiovascular research.

[172]  Ju-Hyun Kim,et al.  Neurological diseases as mortality predictive factors for patients with COVID-19: a retrospective cohort study , 2020, Neurological Sciences.

[173]  Kezhen Li,et al.  Distinct clinical characteristics and risk factors for mortality in female COVID-19 inpatients: a sex-stratified large-scale cohort study in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[174]  J. Arenillas,et al.  Neurological Comorbidity Is a Predictor of Death in Covid-19 Disease: A Cohort Study on 576 Patients , 2020, Frontiers in Neurology.

[175]  A. Pana,et al.  Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study , 2020, Scientific Reports.

[176]  J. Olivier,et al.  Long-term ACE Inhibitor/ARB Use Is Associated With Severe Renal Dysfunction and Acute Kidney Injury in Patients With Severe COVID-19: Results From a Referral Center Cohort in the Northeast of France , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[177]  J. Chen,et al.  Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort , 2020, Clinical Microbiology and Infection.

[178]  P. Bhargava,et al.  Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19 , 2020, International Journal of Infectious Diseases.

[179]  Ary I Savitri,et al.  Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia: An Epidemiological Study. , 2020, Acta medica Indonesiana.

[180]  Suresh Kumar Nayudu,et al.  Predictors of Mortality in Adults Admitted with COVID-19: Retrospective Cohort Study from New York City , 2020, The western journal of emergency medicine.

[181]  X. Xiang,et al.  Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID‐19 patients: Multicenter retrospective study , 2020, Journal of medical virology.

[182]  C. Louapre,et al.  Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis. , 2020, JAMA neurology.

[183]  Xiaofeng Dai,et al.  Epidemiological and clinical characteristics of 671 COVID-19 patients in Henan Province, China , 2020, International journal of epidemiology.

[184]  G. Duan,et al.  The association of hypertension with the severity and mortality of COVID-19 patients: Evidence based on adjusted effect estimates , 2020, Journal of Infection.

[185]  D. Wong,et al.  Impact of chronic liver disease on outcomes of hospitalized patients with COVID‐19: A multicentre United States experience , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[186]  Pankaj Agarwal,et al.  Older age and frailty are the chief predictors of mortality in COVID-19 patients admitted to an acute medical unit in a secondary care setting- a cohort study , 2020, BMC Geriatrics.

[187]  E. Robilotti,et al.  Determinants of COVID-19 disease severity in patients with cancer , 2020, Nature Medicine.

[188]  H. Brenner,et al.  Vitamin D Insufficiency and Deficiency and Mortality from Respiratory Diseases in a Cohort of Older Adults: Potential for Limiting the Death Toll during and beyond the COVID-19 Pandemic? , 2020, medRxiv.

[189]  B. Kostov,et al.  Prognostic factors in Spanish COVID-19 patients: A case series from Barcelona , 2020, medRxiv.

[190]  I. Amat-Santos,et al.  The presence of heart disease worsens prognosis in patients with COVID-19 , 2020, Revista Española de Cardiología (English Edition).

[191]  F. Ozturk,et al.  Prognostic significance of cardiac injury in COVID-19 patients with and without coronary artery disease , 2020, Coronary artery disease.

[192]  Yoon Jung Choi,et al.  Machine learning prediction for mortality of patients diagnosed with COVID-19: a nationwide Korean cohort study , 2020, Scientific Reports.

[193]  A. Mortara,et al.  Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy , 2020, Journal of Endocrinological Investigation.

[194]  Bruce Guthrie,et al.  Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study , 2020, The Lancet Global Health.

[195]  A. Lazzarin,et al.  Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy , 2020, Clinical Immunology.

[196]  X. Chen,et al.  Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study , 2020, Clinical Microbiology and Infection.

[197]  Kipp W. Johnson,et al.  Prevalence and Impact of Myocardial Injury in Patients Hospitalized With COVID-19 Infection , 2020, Journal of the American College of Cardiology.

[198]  Jianfang Liu,et al.  Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages , 2020, Aging.

[199]  M. Dettori,et al.  Deaths in SARS-Cov-2 Positive Patients in Italy: The Influence of Underlying Health Conditions on Lethality , 2020, International journal of environmental research and public health.

[200]  Wei Liu,et al.  Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis , 2020, Heart.

[201]  Yan Zhao,et al.  A Novel Scoring System for Prediction of Disease Severity in COVID-19 , 2020, Frontiers in Cellular and Infection Microbiology.

[202]  Dong Wook Kim,et al.  The Correlation of Comorbidities on the Mortality in Patients with COVID-19: an Observational Study Based on the Korean National Health Insurance Big Data , 2020, Journal of Korean medical science.

[203]  Ignacio J. Amat-Santos,et al.  La presencia de cardiopatía agrava el pronóstico de los pacientes con COVID-19 , 2020, Revista Española de Cardiología.

[204]  L. Mantovani,et al.  Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected Italian citizens , 2020, medRxiv.

[205]  E. Lanza,et al.  Quantitative chest CT analysis in COVID-19 to predict the need for oxygenation support and intubation , 2020, European Radiology.

[206]  Leora I. Horwitz,et al.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.

[207]  Heshui Shi,et al.  Prognostic value of baseline clinical and HRCT findings in 101 patients with severe COVID-19 in Wuhan, China , 2020, Scientific Reports.

[208]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, The Lancet.

[209]  M. Qorbani,et al.  Risk and predictors of in-hospital mortality from COVID-19 in patients with diabetes and cardiovascular disease , 2020, Diabetology & Metabolic Syndrome.

[210]  Naira M Mustafa,et al.  Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis , 2020, Journal of Clinical Virology.

[211]  P. Sullivan,et al.  Similarities and Differences in COVID-19 Awareness, Concern, and Symptoms by Race and Ethnicity in the United States: Cross-Sectional Survey , 2020, Journal of medical Internet research.

[212]  J. Lei,et al.  Clinical Characteristics and Short-Term Outcomes of Severe Patients With COVID-19 in Wuhan, China , 2020, Frontiers in Medicine.

[213]  H. Pan,et al.  Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China , 2020, Transboundary and emerging diseases.

[214]  D. Brodie,et al.  Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study , 2020, medRxiv.

[215]  Haibo Xu,et al.  Scoring systems for predicting mortality for severe patients with COVID-19 , 2020, EClinicalMedicine.

[216]  Robert J. Cerfolio,et al.  Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City , 2020, medRxiv.

[217]  D. Farina,et al.  Radiographic severity index in COVID-19 pneumonia: relationship to age and sex in 783 Italian patients , 2020, La radiologia medica.

[218]  W. Gong,et al.  Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. , 2020, JAMA cardiology.

[219]  Shusheng Li,et al.  Leucocyte Subsets Effectively Predict the Clinical Outcome of Patients With COVID-19 Pneumonia: A Retrospective Case-Control Study , 2020, Frontiers in Public Health.

[220]  L. Xia,et al.  Chest CT imaging features and severity scores as biomarkers for prognostic prediction in patients with COVID-19 , 2020, Annals of translational medicine.

[221]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[222]  Wei Wang,et al.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis , 2020, European Respiratory Journal.

[223]  Huixia Yang,et al.  Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records , 2020, The Lancet.

[224]  B. Eshrati,et al.  Investigating the factors affecting the survival rate in patients with COVID-19: A retrospective cohort study , 2020, Medical journal of the Islamic Republic of Iran.

[225]  Yue Zhou,et al.  Age, gender, and etiology differences of sports-related fractures in children and adolescents , 2019, Medicine.

[226]  L. Hedges,et al.  Basics of meta‐analysis: I2 is not an absolute measure of heterogeneity , 2017, Research synthesis methods.

[227]  Jelle J Goeman,et al.  Plea for routinely presenting prediction intervals in meta-analysis , 2016, BMJ Open.

[228]  A. Badawi,et al.  Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis , 2016, International Journal of Infectious Diseases.

[229]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[230]  Gerta Rücker,et al.  Empirical evaluation suggests Copas selection model preferable to trim-and-fill method for selection bias in meta-analysis. , 2010, Journal of clinical epidemiology.

[231]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, BMJ : British Medical Journal.

[232]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[233]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[234]  Aeschlimann Florence,et al.  Severity of COVID-19 and survival in patients with rheumatic and inflammatory diseases: data from the French RMD COVID-19 cohort of 694 patients , 2021 .

[235]  A. Davarpanah,et al.  Novel coronavirus disease 2019: predicting prognosis with a computed tomography-based disease severity score and clinical laboratory data , 2020 .

[236]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[237]  Bias in meta›analysis detected by a simple, graphical test , 1998 .

[238]  S Greenland,et al.  Quantitative methods in the review of epidemiologic literature. , 1987, Epidemiologic reviews.

[239]  Zejian Zhuang,et al.  Clinical Characteristics of Diabetic Patients with COVID-19 During the Full Liberalization of the Pandemic , 2022 .